The mission of Approxima, just founded startup and Politecnico di Milano Spin off, is to develop the first minimally invasive therapy for tricuspid valve which directly targets the cause of the pathology. This therapy will be offered to wide spectrum of patients, including those who are currently refused for standard surgery. By directly targeting the causes, more stable and effective clinical outcomes are expected, contributing to prolonged lifetime, improved quality of life and reduced reoperations rate.
Company’s Keywords:
<3
<
<
<2020
Your request has been submitted successfully.
Own or work here?